|
TW200904466A
|
|
Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases
|
|
CA2655205A1
|
|
Pan-cell surface receptor- specific therapeutics
|
|
CN101627053A
|
|
Pan-cell surface receptor- specific therapeutics
|
|
CA2628928A1
|
|
Hepatocyte growth factor intron fusion proteins
|
|
KR20080082628A
|
|
Methods for production of receptor and ligand isoforms
|
|
WO2006119510A2
|
|
Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same
|
|
EP1778841A2
|
|
Gastrin-specific interfering rna
|
|
AU2005245896A1
|
|
Cell surface receptor isoforms and methods of identifying and using the same
|
|
CN1997669A
|
|
Monoclonal antibodies to gastrin hormone
|
|
WO2005016966A2
|
|
Intron fusion proteins, and methods of identifying and using same
|
|
EP1839673A2
|
|
Prevention and treatment of hypergastrinemia
|
|
EP1579863A2
|
|
Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors
|
